Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-Dose Cytosine Arabinoside in Elderly Patients With AML

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2013.03.019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Safety of Low Dose Methotrexate in Elderly Patients With Rheumatoid Arthritis

Postgraduate Medical Journal
Medicine
2000English

A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of CXD101 in Patients With Advanced Cancer

Cancer
Cancer ResearchOncology
2018English

A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Phase I Study to Assess the Safety and Tolerability of Olaparib in Combination With Bevacizumab in Patients With Advanced Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2012English

Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Leukemia Research
Cancer ResearchOncologyHematology
2013English

Safety, Tolerability and Immunogenicity of V934/V935 hTERT Vaccination in Cancer Patients With Selected Solid Tumors: A Phase I Study

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

A Phase I Dose‐Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination With Erlotinib in Patients With Advanced Solid Tumors

Oncologist
Cancer ResearchMedicineOncology
2017English

Maintenance of Elderly AML Patients With Androgens

Oncotarget
Oncology
2017English

Efficacy and Tolerability of Low-Dose Perampanel in Patients With Childhood-Onset Intractable Epilepsy

Annals of Child Neurology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy